The global robotic pharmacy prescription market is experiencing significant growth, expanding from USD 214.16 million in 2025 to USD 237.65 million in 2026, with a projected CAGR of 9.18% through 2032, reaching USD 396.21 million. The market is driven by automation adoption for medication safety and efficiency, workforce transformation toward clinical roles, and bundled solution procurement strategies across hospitals, clinics, and long-term care facilities.

The biopharmaceutical third-party logistics market is expected to grow from $140.03 billion in 2025 to $384.23 billion by 2032, with a CAGR of 15.51%. Growth is driven by rising product complexity, regulatory scrutiny, cold chain integrity demands, and technological advancements in digital tracking and specialized handling for biologics and gene therapies.

The article examines three high-ROIC dividend-paying stocks: MasterCard, which reported strong Q4 2025 earnings with 17.3% revenue growth and 19% annual EPS growth; Starbucks, showing accelerating comparable store sales growth to 4% with expansion opportunities in China; and Cardinal Health, a major drug distributor posting 18.6% revenue growth and 39 consecutive years of dividend increases.

The global medical device cleaning market is projected to grow from USD 2.08 billion in 2024 to USD 3.74 billion by 2032, driven by escalating infection prevention requirements, expanding reusable device utilization, and technological advancements in automated reprocessing systems. However, high capital costs, complex regulatory obligations, and workforce training variability pose challenges to uniform adoption across regions.

Cardinal Health's Board of Directors approved a quarterly dividend of $0.5107 per share, payable on April 15, 2026 to shareholders of record as of April 1, 2026. The dividend will be paid from the company's capital surplus.

Cardinal Health (CAH) surged 9.11% to a new 52-week high after reporting strong Q2 results with adjusted EPS of $2.63 (beating consensus of $2.35) and sales of $65.63 billion (+19% YoY). The company raised its fiscal 2026 guidance for adjusted EPS to $10.15-$10.35 (+23% to +26% growth) and raised profit growth guidance across multiple segments.

Medline Industries, the largest IPO of 2025, is positioned as an attractive investment opportunity. The Chicago-based medical supply company has demonstrated strong historical growth with 18% average annual sales growth since 1966 and 50 consecutive years of net sales growth. With a $375 billion total addressable market and solid free cash flow projections, analysts expect continued momentum, though the stock trades at a lofty P/E multiple of 28.

A comprehensive market report on the U.S. Personal Protective Equipment market covering gowns, masks, face shields, gloves and other segments through 2033. The report provides revenue, volume, and pricing data across market segments with company share information for 2024, identifying key opportunities for market entry, expansion, and investment strategies.

AOP Health US announced expanded distribution of Rapiblyk™ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing accessibility for hospitals and health systems nationwide.

The global pharmaceutical waste management market is projected to grow at a CAGR of 5.91% from 2026 to 2032, reaching USD 2631.59 million by 2032, up from USD 1662.35 million in 2024. Growth is driven by stringent regulatory frameworks, expanding pharmaceutical industry, and rising sustainability focus, though high operational costs and fragmented regulations present challenges.

The global adhesive bandages market is expected to grow to $4.48 billion by 2032, driven by rising minor injuries, increased healthcare awareness, and product innovations, despite challenges like skin irritation and pricing pressures.

The article highlights three dividend stocks with strong potential: Cardinal Health, Chevron, and Target. Each company offers unique dividend growth opportunities based on their financial performance, transformation strategies, and commitment to shareholder returns.